About

Dr. Taiping Zhang is a leading figure in pancreatic surgery, with a focused expertise in advancing minimally invasive techniques, particularly robotic-assisted procedures. His major contributions center on rigorously evaluating the safety, efficacy, and learning curves of robotic pancreaticoduodenectomy (RPD) and distal pancreatectomy (RDP). A landmark 2022 meta-analysis, with 26 citations, critically compared robotic versus open pancreaticoduodenectomy, providing high-level evidence on perioperative outcomes for all patients and specifically those with pancreatic cancer. Dr. Zhang has also pioneered research on the learning curve for these complex operations, including a single-center study of 301 RDP cases (16 citations) and an analysis of a surgeon transitioning from laparoscopic to robotic PD. Beyond surgical technique, he investigates healthcare economics, as shown by his 2024 study on DRG payment models for major pancreatic surgery. His work is instrumental in defining best practices for implementing robotic surgery, demonstrating its feasibility and safety, and shaping the future of pancreatic cancer care.

Research Focus

Key Achievements

4
H-Index
5
Papers
60
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients
26 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago